Hip Abductor Muscle Weakness in Individuals with Gluteal Tendinopathy.

• Autores: Jim Allison, Bill Vicenzino, Tim V. Wrigley, Alison Grimaldi, Paul W. Hodges, Kim L. Bennell
• Localización: Medicine & Science in Sports & exercise: Official Journal of the American College of Sports Medicine, ISSN 0195-9131, Vol. 48, Nº. 3, 2016, págs. 346-352
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • AB Purpose: This study aimed to compare hip abductor muscle strength between individuals with symptomatic, unilateral gluteal tendinopathy (GT), and asymptomatic controls. Methods: Fifty individuals with GT age between 35 and 70 yr and 50 sex- and age-comparable controls were recruited from the community. Maximal isometric strength (torque normalized to body mass) of the hip abductors was recorded in the supine position using an instrumented manual muscle tester. A two-way mixed ANCOVA, with covariates of self-reported pain during testing and pain limiting maximum effort, was used to compare hip abductor strength of the symptomatic and asymptomatic hip between GT and control individuals. Data were expressed as mean and SD, with the pairwise comparisons expressed as mean differences and 95% confidence intervals. Results: Individuals with GT demonstrated significantly lower hip abductor torque of both their symptomatic and asymptomatic hip than healthy controls (both P < 0.05), with mean strength deficits of 0.35 N[middle dot]m[middle dot]kg-1 (32%) on the symptomatic hip and 0.25 N[middle dot]m[middle dot]kg-1 (23%) on the asymptomatic hip. In individuals with GT, the symptomatic hip was significantly weaker than the asymptomatic hip with a mean strength deficit of 0.09 N[middle dot]m[middle dot]kg-1 (11%) (P < 0.05). Conclusions: People with unilateral GT demonstrate significant weakness of the hip abductor muscles bilaterally when compared with healthy controls. Although it is not clear whether hip weakness precedes GT or is a consequence of the condition, the findings provide a basis to consider hip abductor muscle weakness in the treatment plan for management of GT